Switching to high genetic-barrier integrase inhibitors reduces drug-drug interactions in people living with HIV

被引:0
|
作者
Nashier, Chhavi [1 ]
Askari, Ara [2 ]
Ghelani, Rahul [2 ]
Zhang, Adrian Vargas [1 ]
Ng, Megan [1 ]
Karagozlu, Zekiye [1 ]
Bracchi, Margherita [2 ]
Moyle, Graeme [2 ]
Asboe, David [2 ]
Boffito, Marta [2 ]
机构
[1] Imperial Coll London, London, England
[2] Chelsea & Westminster Hosp Fdn Trust, London, England
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
P005
引用
收藏
页码:24 / 24
页数:1
相关论文
共 50 条
  • [21] Prevalence and management of drug-drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study
    Schlaeppi, C.
    Vanobberghen, F.
    Sikalengo, G.
    Glass, T. R.
    Ndege, R. C.
    Foe, G.
    Kuemmerle, A.
    Paris, D. H.
    Battegay, M.
    Marzolini, C.
    Weisser, M.
    HIV MEDICINE, 2020, 21 (01) : 53 - 63
  • [22] Antiretrovirals and frequently prescribed medications in people living with HIV: Potential drug-drug interactions detected by three online-databases
    Jiso, Apisada
    Thiengtham, Kanaporn
    Suwannakhan, Athikhun
    Sirijaraswan, Nunnaphat
    Khemawoot, Phisit
    Sungkanuparph, Somnuek
    PHARMACY PRACTICE-GRANADA, 2024, 22 (02):
  • [23] Use of comedications and potential drug -drug interactions in people living with HIV in China
    Chen, Rong
    Chen, Jun
    Tang, Qi
    Meng, Zhihao
    Luo, Ling
    Zhang, Wei
    Deng, Aihua
    Zhang, Lukun
    Wang, Jiangrong
    Qi, Tangkai
    Zhang, Renfang
    Shen, Yinzhong
    Liu, Li
    Steinhart, Corky
    Lu, Hongzhou
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (07) : 722 - 728
  • [24] Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain
    Castro-Granell, Vanessa
    Garin, Noe
    Jaen, Angeles
    Cenoz, Santiago
    Jose Galindo, Maria
    Fuster-Ruizde Apodaca, Maria Jose
    PLOS ONE, 2021, 16 (11):
  • [25] Sunscreen ingredients in plasma: a threat for drug-drug interactions and toxicity among patients living with HIV?
    Maggi, Paolo
    Brancaccio, Giuseppina
    Gaeta, Giovanni B.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (10) : 775 - 778
  • [26] Polypharmacy and risk of admission to hospital in people ageing with HIV: what is the contribution of drug-drug interactions?
    Allavena, Clotilde
    Marzolini, Catia
    LANCET HEALTHY LONGEVITY, 2021, 2 (10): : E606 - E607
  • [27] Fostemsavir to overcome drug-drug interactions in heavily treatment-experienced people with HIV and cancer
    Giacomelli, Andrea
    Cattaneo, Dario
    Pozza, Giacomo
    Moschese, Davide
    Cossu, Maria Vittoria
    Dalu, Davide
    Gervasoni, Cristina
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (07) : 1708 - 1709
  • [28] Potential drug-drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey
    Tinggaard, Michaela
    David, Kim Peter
    Gerstoft, Jan
    Hansen, Ann-Brit Eg
    Kirk, Ole
    Lebech, Anne-Mette
    Lindhardt, Bjarne Orskov
    Rose, Michala Vaaben
    Ryom, Lene
    Weis, Nina
    Benfield, Thomas
    HIV MEDICINE, 2023, 24 (01) : 46 - 54
  • [29] Potential drug-drug interactions between the antiretrovirals and frequently prescribed medications in people living with HIV, detected by three electronic databases.
    Thiengtham, Kanaporn
    Jiso, Apisada
    Suwannakhan, Athikhun
    Khemawoot, Phisit
    Vivithanaporn, Pornpun
    Sungkanuparph, Somnuek
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 1187 - 1187
  • [30] Polypharmacy and drug drug interactions in older and younger people living with HIV: the POPPY study
    Halloran, Marie O.
    Boyle, Catherine
    Kehoe, Brona
    Bagkeris, Emmanouil
    Mallon, Paddy
    Post, Frank A.
    Vera, Jamie
    Williams, Ian
    Anderson, Jane
    Winston, Alan
    Sachikonye, Memory
    Sabin, Caroline
    Boffito, Marta
    ANTIVIRAL THERAPY, 2019, 24 (03) : 193 - 201